---
figid: PMC8192181__JIR2021-9944880.005
figtitle: Anti-inflammatory Effects of Empagliflozin and Gemigliptin on LPS-Stimulated
  Macrophage via the IKK/NFKB, MKK7/JNK, and JAK2/STAT1 Signalling Pathways
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC8192181
filename: JIR2021-9944880.005.jpg
figlink: /pmc/articles/PMC8192181/figure/fig5/
number: F5
caption: Proposal of a proinflammatory pathway inhibited by empagliflozin (SGLT2 inhibitor)
  and gemigliptin (DPP-4 inhibitor) in LPS-activated RAW 264.7 macrophages.
papertitle: Anti-inflammatory Effects of Empagliflozin and Gemigliptin on LPS-Stimulated
  Macrophage via the IKK/NF-ÎºB, MKK7/JNK, and JAK2/STAT1 Signalling Pathways.
reftext: Nami Lee, et al. J Immunol Res. 2021;2021:9944880.
year: '2021'
doi: 10.1155/2021/9944880
journal_title: Journal of Immunology Research
journal_nlm_ta: J Immunol Res
publisher_name: Hindawi
keywords: ''
automl_pathway: 0.9449129
figid_alias: PMC8192181__F5
figtype: Figure
redirect_from: /figures/PMC8192181__F5
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8192181__JIR2021-9944880.005.html
  '@type': Dataset
  description: Proposal of a proinflammatory pathway inhibited by empagliflozin (SGLT2
    inhibitor) and gemigliptin (DPP-4 inhibitor) in LPS-activated RAW 264.7 macrophages.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CHUK
  - IKBKB
  - NFKB1
  - PTGS2
  - IRF6
  - JAK2
  - NOS2
  - ISYNA1
  - STAT3
  - TNF
  - IL16
  - IL6
  - MAP2K4
  - MAP2K7
  - MAPK8
  - MAPK9
  - MAPK10
  - CCL3
  - CCL5
  - CXCL10
  - CXCL11
  - CXCL12
  - CXCL13
  - CXCL14
  - CXCL9
  - PF4
  - CXCL1
  - CXCL2
  - CXCL3
  - CXCL5
  - CXCL6
  - CXCL8
  - PPBP
---
